Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 99.95
+6.05 (6.44%)
Jul 29, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 160.52 billion as of July 29, 2025. Its market cap has increased by 166.41% in one year.
Market Cap
160.52B
Enterprise Value
155.14B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
99.95
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 160.52B, an increase of 765.83%. That is a compound annual growth rate of 37.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 160.52B | 167.72% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | 115.10B | 243.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Akeso | 133.83B |
| WuXi Biologics | 128.18B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 84.65B |